[ad_1] Itâs fair to say that Nasdaq chip stock Micron (NASDAQ: MU) is hot right now. Over the last year, it has surged about 350% amid an AI-related memory âsupercycleâ. Now, Iâve completely missed out on these explosive gains sadly.…
[ad_1] Transaction SELL 8,508 shares Total Value $2.8M @ $88.09/share Insider President & CEO Jackson Peter M. CEO leads executive tax withholding wave. Builders FirstSource President & CEO Peter M. Jackson surrendered 8,508 shares at $88.09 per share on March…
[ad_1] UK shares have performed well recently. However, investors shouldnât overlook international shares â in markets such as the US and Europe there are some really attractive opportunities today. One international stock that I believe is worth a look is…
[ad_1] Transaction SELL 1,491 shares Total Value $1.1M @ $535.72/share Insider President and CEO Steelman Kecia CEO tax withholding transaction. Kecia Steelman, President and CEO of Ulta Beauty, Inc. (ULTA), surrendered 1,491 shares at $535.72 per share to satisfy tax…
[ad_1] It can be hard to buy stocks when their prices are going down. We all love a bargain but few want to buy something that may well be cheaper tomorrow or next week. But investing at times like these…
[ad_1] Transaction SELL 16,130 shares Total Value $219K @ $13.60/share Insider CEO and President Turner John Gregory CEO forfeits shares for tax withholding. John Gregory Turner, CEO and President of Atlas Energy Solutions Inc. (NYSE: AESI), surrendered 16,130 shares at…
[ad_1] I’ve had my fingers a little burnt since buying FTSE 250 tech share Softcat (LSE:SCT) in January. It’s fallen sharply in recent months, on worries over how artificial intelligence (AI) models will disrupt the software sector. The company was…
[ad_1] Transaction SELL 15,000 shares Total Value $337K @ $15.16/share Insider President and CEO Grossman Adam S CEO sells $227,400 in shares. Adam S. Grossman, President and CEO of ADMA Biologics Inc (NASDAQ: ADMA), sold 15,000 shares at $15.16 per…
[ad_1] Rolls-Royce might attract more fanfare, but Fresnillo (LSE:FRES) shares have minted investors a fortune over the past year. In this time, they’ve soared 243%, with cascading dividends on top. However, the FTSE 100 stock has come off the boil…
[ad_1] Earnings Per Share (GAAP) $0.06 Swings to profit. Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q4 2025 GAAP EPS of $0.06. The biotechnology company swung to profitability from a year-ago loss of $0.13 per share. Net income reached $9.7 million…